Clinical Trial Update: PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. [Phase 3]

View source ↗

Summary

Phase III open, randomized trial evaluating PFLL with a PD-1 antibody, with or without fecal microbiota transplantation, for oligometastatic nasopharyngeal carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• PFLL

Snippet

Sponsor: Yun-fei Xia | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING